Silence Therapeutics Plc

SLN:LN

Overview

Company Profile

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Classification

Sector Healthcare

Industry Biotechnology & Life Sciences

Subindustry Biotechnology

Market Sectors

Gunsynd shares tick up on positive Talon Resources news

Cadence Minerals joins the ranks of the producers

Chart Rundown: November 12

RNS Hotlist November 12: Arrow Exploration, Atomic Metals, Buccaneer, Oxford Biodynamics, Talon, Tooru

Altius to acquire TNR Gold in C$122 million deal, Shotgun to be spun out

Edison - Regional REIT:Steady strategic progress

Edison - Drax Group:Grid access opens a data centre option

Edison - Baker Steel Resources Trust – equity proposition

Edison - IP Group:Assessing Pfizer’s anti-obesity royalty potential

Kepler | Trust Intelligence - Henderson High Income

Kepler | Trust Intelligence - F&C Investment Trust

Mining Matters: Gold, Trump and Datacentres

Ed Loye talks Trenching at Dough God

Zeus says Rift Helium could be worth multiples of current share price

Mining Matters - Cavendish says Blencowe Resources shares could go 500% higher

Oriole has 1.2 million ounces of gold from surface at Mbe

Silence Therapeutics Plc

Overview

Company Profile

Classification

Corporate